DRCR Retina Network for Diabetic and Other Retinal Eye Conditions
Official title: DRCR Network
Funded at Jaeb Center for Health Research, INC. · NIH-11285242 · Data updated 2026-11-12
A nationwide research network running clinical studies to improve treatments and care for people with diabetic retinopathy, age-related macular degeneration, and other retinal diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jaeb Center for Health Research, INC. NIH-funded |
| Lab location | 1 site (Tampa, UNITED STATES) |
| Project start | September 30, 2002 |
| Project end | December 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $8,500,000 |
| NIH project number | 5UG1EY014231-25 |
| Project ID | NIH-11285242 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, or other retinal retinal diseases who meet specific eligibility criteria at participating U.S. clinics are the typical candidates.
✕Less likely to help
People without retinal disease or those who do not meet trial eligibility (for example because of other serious medical conditions) are unlikely to receive direct benefit from current network studies.
What this research studies
As a patient, this network runs large clinical trials and observational studies at more than 100 eye clinics across the United States so I could join a study near my home. Studies are coordinated through a central center and use standardized retinal imaging, centralized image reading centers, and common protocols to compare treatments, test new drugs or devices, and track outcomes like vision and quality of life. The network focuses on diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and other retinal diseases and collects clinical data, images, and patient-reported information. Because the DRCR network is a standing infrastructure with experienced investigators, its studies can be large and influence care more quickly than single-site trials.
Why it matters
Potential benefit: If successful, the work could produce safer, more effective treatments and clearer care guidelines that help prevent vision loss and improve daily functioning.
How similar studies have gone: Previous DRCR Network trials have already changed clinical practice and improved visual outcomes in diabetic eye disease, so this network's approach has a strong track record.
Where this research is happening
-
Jaeb Center for Health Research, INC.
Tampa, United States Active
Researchers
- Principal investigator: Glassman, Adam R — Jaeb Center for Health Research, INC.
- Study coordinator: Glassman, Adam R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.